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Abstract
HMG-CoA reductase and the LDL receptor are ubiquitously expressed in major tissues. Since the
liver plays a major role in regulating circulating LDL, it is usually of interest to measure the effects
of drug or dietary interventions on these proteins in liver. In humans, peripheral blood
mononuclear cells have been used as a surrogate for liver to assess regulation of these genes,
although there is concern regarding the validity of this approach. The purpose of this study was to
evaluate the relationship between liver and mononuclear cell expression of HMG-CoA reductase
and the LDL receptor in guinea pigs, a well established model for human cholesterol and lipoprotein
metabolism. We extracted RNA from liver and mononuclear cells of guinea pigs from a previous
study where the effects of rapamycin, an immunosuppresant drug used for transplant patients, on
lipid metabolism were evaluated. Guinea pigs were assigned to three different diets containing the
same amount of fat (15 g/100 g) and cholesterol (0.08 g/100 g) for a period of 3 weeks. The only
difference among diets was the concentration of rapamycin: 0, 0.0028 or 0.028 g/100 g. There were
no differences in plasma LDL cholesterol (LDL-C) among groups. Values were 78.4 ± 14.3, 65.8 ±
17.2 and 68.4 ± 45.4 mg/dL (P > 0.05) for guinea pigs treated with 0, low or high doses of rapamycin,
respectively. The mRNA abundance for the LDL receptor and HMG-CoA reductase was measured
both in liver (n = 30) and mononuclear cells (n = 22) using reverse transcriptase PCR. In agreement
with the finding of no changes in plasma LDL-C, there were also no differences for the expression
of HMG-CoA reductase or the LDL receptor among groups. However, a positive correlation was
found between liver and mononuclear cells for both HMG-CoA reductase (r = 0.613, P < 0.01) and
the LDL receptor (r = 0.622, P < 0.01). These correlations suggest that monocytes can be used in
humans as an index for liver to assess diet and drug effects on the expression of HMG-CoA
reductase and the LDL receptor.
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Findings
Although cholesterol is an extremely important biological
molecule with a major role in membrane structure as well
as a precursor for the synthesis of steroid hormones and
bile acids, excessive cholesterol, is involved in atheroscle-
rotic lesions. Therefore, a balance must be maintained
between cholesterol absorption, excretion and endog-
enous cholesterol synthesis. In this regard, the liver plays
an important role in controlling the amount and compo-
sition of circulating LDL cholesterol (LDL-C) levels [1].
For example, under increased dietary cholesterol chal-
lenge, the LDL receptor, responsible for the uptake of
LDL-C is downregulated [1]. Under similar conditions the
rate limiting enzyme of cholesterol synthesis, 3-hydroxy-
3methyl glutaryl Coenzyme A (HMG-CoA) reductase is
also downregulated [2] and at the same time cholesterol
7α-hydroxylase (CYP7), responsible for catabolism of
cholesterol as bile, is upregulated [3] as part of a compen-
satory mechanism in the liver. Experiments aimed
towards the evaluation of drug or dietary interventions
conducted in animals rely highly on the liver to evaluate
major mechanisms responsible for alterations of plasma
lipids. Unfortunately, the liver is not readily accessible
during clinical trials. In various human studies, mononu-
clear cells have been reported to be used as surrogates for
liver to estimate hepatic expression of various genes
involved in cholesterol metabolism; however, the extent
to which mononuclear cells reflect hepatic expression can
be questioned [4,5]. Major proteins involved in choles-
terol metabolism present in liver are also ubiquitously
expressed in other tissues. HMG-CoA reductase and the
LDL receptor are clear examples of such proteins. The
main purpose of this study was the validation of gene
expression in mononuclear cells as marker of hepatic cho-
lesterol metabolism. Guinea pigs were used as the animal
model because of their well documented similarities to
humans in terms of cholesterol and lipoprotein metabo-
lism [6]. In addition, previous studies performed in our
laboratory have reported that guinea pigs serve as a good
model for evaluating diet and drugs affecting lipid metab-
olism [6,7]. We used liver and mononuclear cells that
were available from guinea pigs treated with rapamycin
where no effects were seen on plasma LDL cholesterol.
Thus we were not expecting an effect on LDL receptor or
HMG-CoA reductase expression due to treatment [8].
Methods
Diets and animals
Diets were designed to meet the nutritional requirements
of guinea pigs. All diets contained the same amount of fat,
15 g/100 g and of dietary cholesterol, 0.08 g/100 g and
they only varied in the amount of rapamycin (0, 0.0028
or 0.028 g/100 g). Thirty male guinea pigs (Sprague Daw-
ley, Elm Hills Lab) (n = 10 per group) were used for this
experiment [8]. Guinea pigs consumed the diets for 3
weeks and diets were weighed daily to determine the
amount of food consumed. Guinea pigs were deprived of
food overnight and sacrificed by heart puncture after iso-
flurane anesthesia. Blood was obtained via heart punc-
ture. After euthanasia, the liver was removed, wrapped in
labeled, precooled aluminum foil, and then snap frozen
in liquid nitrogen and stored immediately at -80°C until
the day of RNA extraction. Experimental protocols were
approved by the University of Connecticut Institutional
Animal Care and Use Committee.
Mononuclear cell isolation
Mononuclear cells were isolated from whole blood by
centrifugation on a Ficoll gradient by the method of
Boyum [9]. Briefly, 20 ml blood was diluted with 10 ml
HBSS without Ca2+ and Mg2+, layered over 10 ml Histo-
paque® 1077 and centrifuged at 500 × g for 30 minutes.
The mononuclear cell interface was removed, and washed
with HBBS and centrifuged at 600 × g for 10 minutes
twice. The cell pellet was resuspended in 200 µl Tris buffer
(10 mM Tris, 150 mM NaCl, 1 mM CaCl2, pH 7.4), and
kept at -80°C until RNA was extracted.
RNA extraction
Total RNA was extracted from the liver and mononuclear
cells by the method of Chomczynski et al. [10]. To check
the integrity of the extracted RNA, samples were electro-
phoresed through a 1% agarose gel at 125 V for 45 min-
utes. Two clear sharp bands represented 28 S and 18 S
ribosomal fraction of RNA (data not shown).
RNA quantification
HMG-CoA reductase and LDL receptor mRNA abundance
were determined from liver and mononuclear cell extracts
using a semi-quantitative RT-PCR method adapted from
that of Powell and Kroon [11]. The RT-PCR reaction was
carried out using a Qiagen One Step RTPCR kit in a Gene
Amp® PCR system 9700 (Applied Biosystems, CA) thermal
cycler. Oligonucleotide primers used for amplification
were those used for HMG-CoA reductase [12] and the LDL
receptor in humans [13]. The primers used for β-actin, a
house keeping gene, were taken from guinea pig
sequences and have been previously reported [14]. The
approximate size of each reaction product is as follows:
HMG-CoA reductase : 255 bp, LDL receptor : 240, and β-
actin: 220 bp. β-Actin was used as a control in all reac-
tions. The reaction mixture contained 1.0 µg of total RNA.
Amplification was carried out at an annealing temperature
of 56° for 35 cycles for HMG-CoA reductase, 56° for LDL
receptor for 32 cycles, 56° for β-actin for 27 cycles. Ten µL
of each reaction mixture was size fractionated by electro-
phoresis in a 1% agarose gel, in 1% Tris-borate/EDTA
buffer. Bands were visualized by staining with ethidium
bromide. The amplified RT-PCR products were electro-
phoresed through a 1% agarose gel at 125 V for 45 min-Lipids in Health and Disease 2006, 5:22 http://www.lipidworld.com/content/5/1/22
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utes. Band sizes were identified using a DNA molecular
marker.
Products were then quantified by measuring the relative
band intensity using The Image J program (NIH). Band
intensities were corrected based on the β-actin signal.
Results
There were no differences in plasma cholesterol among
groups although there were individual differences in
guinea pigs ranging from 34 to 173 mg/dL. Mean values
were 78.4 ± 14.3, 65.8 ± 17.2 and 68.4 ± 45.4 mg/dL for
the 0, low and high rapamycin, respectively. In agreement
with these data, there were no significant differences in
the expression of the LDL receptor or HMG-CoA reductase
among groups. The relative values for mononuclear cell
HMG-CoA reductase expression were 2.61 ± 2.33, 1.95 ±
1.85 and 1.39 ± 1.52 for control, low and high rapama-
cyn, respectively while the corresponding values for the
liver were 1.54 ± 1.90, 0.81 ± 0.91 and 0.77 ± 1.04. Simi-
larly, there was no treatment effect for the LDL receptor.
The relative values for 0, low and high rapamycin in the
liver were 1.13 ± 1.24, 4.6 ± 4.96 and 2.09 ± 1.91 and the
corresponding values in the mononuclear cells were 1.21
± 0.75, 1.64 ± 2.24, and 1.62 ± 3.33. A strong positive cor-
relation was found between the expression of HMG-CoA
reductase in the liver and in the mononuclear cells (r =
0.613, P < 0.01) (Figure 1, panel A). The expression of
LDL receptor in liver and mononuclear cells were also
positively correlated (r = 0.623, P < 0.01) (Figure 1, Panel
B).
Discussion
The current study provided an opportunity to study gene
expression in both liver and mononuclear cells to validate
mononuclear cells as surrogates of hepatic expression of
HMG-CoA reductase and the LDL receptor.
The liver being a biologically active organ is often har-
vested to study the activity and expression of various pro-
teins affected by dietary interventions or drug treatment
[2,8]. Analysis of hepatic enzymes or receptors is feasible
(Panel A) Correlation between liver and mononuclear cells for the expression of HMG-CoA reductase (n = 30) Figure 1
(Panel A) Correlation between liver and mononuclear cells for the expression of HMG-CoA reductase (n = 30). (Panel B) Cor-
relation between liver and mononuclear cells for the expression of the LDL receptor (n = 22).
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in animal studies but it becomes a limiting factor in
human studies thus the use of mononuclear cells becomes
a desirable option. However, there has always been a con-
cern whether the generated data truly represent hepatic
activity. However, there is one study conducted in
humans which demonstrated that the mechanisms which
regulate mRNA levels in liver and mononuclear cells are
similar and suggested that mononuclear cells can be used
to predict HMG-CoA reductase and LDL receptor mRNA
levels in liver [15]. The functionality of the LDL receptor
has been shown in mononuclear cells in which the con-
centration of both protein and mRNA were evaluated in
subjects who had been treated with plant stanol [16].
Another study reported an increased expression of HMG-
CoA reductase for human mononuclear cells in subjects
consuming 10 g/d of psyllium for one month [4], results
which are in agreement with hepatic HMG-CoA reductase
activity being up-regulated in guinea pigs after psyllium
consumption [17]. In addition, previous studies in our
laboratory have shown that the decreases in LDL-C
observed following a weight reduction program were cor-
related with increased expression of the LDL receptor in
human mononuclear cells [5].
The positive correlation found between the expression of
the LDL receptor and HMG-CoA reductase in liver and
mononuclear cells in the current study supports the meas-
urement of the expression of these two ubiquitously dis-
tributed proteins in human mononuclear cells as a
surrogate for hepatic cholesterol metabolism.
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